Plain-English translation of NCT03932279 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying the microbiome—the community of bacteria and other microorganisms living on and in your body—in people with cutaneous T cell lymphoma, a rare blood cancer that affects the skin. By comparing the microbiome of patients at different disease stages to healthy volunteers and people with other skin conditions, the researchers hope to understand whether bacteria play a role in how this disease develops or progresses.
Very little is known about how the microbiome influences cutaneous T cell lymphoma. By mapping and comparing bacteria in patients versus healthy people, doctors may discover new clues about what causes the disease or how to treat it better.
You likely qualify if…
You likely don't qualify if…
As a participant, you would provide skin and stool samples that researchers will analyze to identify and compare the bacteria present. The study is observational, meaning you are not receiving a new treatment—researchers are simply collecting biological samples and studying them in the laboratory. Visit details and duration are not specified in this summary, so you should contact the study team at Northwestern University for specifics about time commitment and location.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
Northwestern University
Enrollment target
~300 participants
Started
January 2019
Primary completion
February 2028
Age range
18 Years – 89 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dermatology CTU
Northwestern University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.